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A B S T R A C T
Recent work has shown that two bumblebee (Bombus terrestris) cytochrome P450s of the CYP9Q subfamily,
CYP9Q4 and CYP9Q5, are important biochemical determinants of sensitivity to neonicotinoid insecticides. Here,
we report the characterisation of a third P450 gene CYP9Q6, previously mis-annotated in the genome of B.
terrestris, encoding an enzyme that metabolises the N-cyanoamidine neonicotinoids thiacloprid and acetamiprid
with high eﬃciency. The genomic location and complete ORF of CYP9Q6 was corroborated by PCR and its
metabolic activity characterised in vitro by expression in an insect cell line. CYP9Q6 metabolises both thiacloprid
and acetamiprid more rapidly than the previously reported CYP9Q4 and CYP9Q5. We further demonstrate a
direct, in vivo correlation between the expression of the CYP9Q6 enzyme in transgenic Drosophila melanogaster
and an increased tolerance to thiacloprid and acetamiprid. We conclude that CYP9Q6 is an eﬃcient metaboliser
of N-cyanoamidine neonicotinoids and likely plays a key role in the high tolerance of B. terrestris to these
insecticides.
1. Introduction
The buﬀ-tailed bumblebee, Bombus terrestris (Hymenoptera: Apidae)
is one of the most abundant bumblebee species in Europe and an im-
portant pollinator of wild plants and crops. Domesticated colonies are
used for managed pollination of crops in orchards and greenhouses and
are one of the main commercial alternatives to the western honey bee,
Apis mellifera (Goulson, 2010; Velthuis and van Doorn, 2006). Apart
from their commercial importance bumblebees are also used as a model
species for bee population genetics and the study of insect behaviour
(Woodard et al., 2015).
The eﬀect of xenobiotics on the health of bee pollinators has been
the focus of considerable recent research, particularly in relation to the
extensive use of synthetic insecticides in agriculture (Goulson et al.,
2015). The eﬀect of insecticidal exposure on the overall ﬁtness of in-
dividuals and colonies of this species is still a topic of active in-
vestigation (Potts et al., 2018; Wu-Smart and Spivak, 2018). However,
concerns over the eﬀects of three N-nitroguanidine neonicotinoid
insecticides, imidacloprid, thiamethoxam and clothianidin on bee pol-
linators, including B. terrestris, has led the European Union to ban these
compounds for use on ﬁeld crops (Cressey, 2017). Due to their high
acute intrinsic toxicity to B. terrestris these three compounds are all
classiﬁed as ‘highly toxic’ according to the categories delineated by the
U.S. Environmental Protection Agency (Manjon et al., 2018). In con-
trast B. terrestris exhibits a marked tolerance to N-cyanoamidine neo-
nicotinoids, with thiacloprid classiﬁed as ‘practically non-toxic’ in acute
contact bioassays (U.S.E.P. Agency, 2014; Manjon et al., 2018). Similar
diﬀerences have been described for the toxicity of the N-ni-
troguanidines and N-cyanoamidines to the western honey bee, A. mel-
lifera (Manjon et al., 2018), and the solitary red mason bee, Osmia bi-
cornis (Beadle et al., 2019).
Recent research has provided a biochemical explanation for this
observed diﬀerential sensitivity and shown that, in all three bee species,
P450 enzymes from the CYP9 family eﬃciently detoxify N-cyanoami-
dine compounds but have little activity against N-nitroguanidine
compounds, thus acting as molecular determinants of bee sensitivity to
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neonicotinoids (Beadle et al., 2019; Manjon et al., 2018). In B. terrestris
two P450s, CYP9Q4 and CYP9Q5, were previously shown to eﬃciently
metabolise the N-cyanoamidine neonicotinoids thiacloprid and acet-
amiprid; however their overall combined activity in enzyme assays was
signiﬁcantly lower than that of CYP9Q3, the primary P450 metabo-
lising these neonicotinoids in A. mellifera, leading us to speculate that
additional P450s may play a role in neonicotinoid metabolism in
bumblebees (Manjon et al., 2018). Here we report the identiﬁcation and
functional characterisation of a novel CYP9Q from B. terrestris, CYP9Q6,
and demonstrate it to be an eﬃcient detoxiﬁer of N-cyanoamidine
neonicotinoids.
2. Methods
2.1. Insects and chemicals
Worker bees used for the experiments came from Bombus terrestris
commercial colonies (standard hives) supplied by Biobest (Belgium).
Colonies were kept in the dark at 27±1 °C, 50% relative humidity. All
chemicals were supplied by Sigma-Aldrich unless stated otherwise.
2.2. Preparation of nucleic acids
DNA and RNA extractions were done on single adult worker bees.
DNA was extracted using the E.Z.N.A. Insect DNA kit (Omega-BioTek,
USA) following the manufacture's protocol. Total RNA was extracted
using Triazol reagent (ThermoScientiﬁc, USA) following the manufac-
turer's protocol. 4 μg of RNA was used for cDNA synthesis using
SuperScript® III reverse transcriptase (Life Technologies, USA) with
OligodT(15) primer (Promega, USA).
2.3. RT-PCR, sub-cloning and sequencing
PCR was performed using pfu polymerase (Promega, USA) in 25 μl
reactions containing; 1 μl of cDNA or genomic DNA template, 10 pmol
of each forward and reverse primer (see Supplementary Table 1 for
primer details), and 1.5U of enzyme. Cycling conditions comprised an
initial denaturation at 95 °C for 3min, followed by 35 cycles of 95 °C for
20s, 55 °C for 30s, 72 °C for 4min, with a ﬁnal extension step at 72 °C
for 5min. PCR amplicons were separated using 1% w/v TAE gel elec-
trophoresis, and products of the expected size were excised from the gel
and recovered using Qiaquick gel extraction kit (Qiagen, Germany),
following the manufacturer's protocol. PCR products were sequenced
directly using Euroﬁns value read service (Germany). Bands which re-
presented full-length ORF were further ligated into the pJET 1.2 vector
of GeneJET PCR cloning kit (ThermoScientiﬁc, USA), and transformed
into XL-1 blue cells (Agilent, USA). Plasmid preps were prepared using
a GeneJET mini-prep kit (ThermoScientiﬁc, USA), following the man-
ufacturer's protocol.
2.4. Tissue-speciﬁc qPCR
Bumblebees were dissected in PBS (phosphate buﬀered saline)
buﬀer, and total RNA was prepared from tissues of a single female
worker as described above. Two μg of RNA was used for cDNA synthesis
as described above. PCR reactions (15 μl) contained 4 μl of cDNA (di-
luted 1:10 v/v), 7.5 μl of SYBR® Green JumpStart™ Taq ReadyMix
(Sigma-Aldrich, USA), and 0.25 μM of each primer (Supplementary
Table 1). Cycling conditions comprised 3min at 95 °C, followed by 39
cycles of 95 °C for 15s, 64 °C for 15s and 60 °C for 15s. A ﬁnal melt-
curve step was included post-PCR (ramping from 65 to 95 °C by 0.5 °C
every 5s) to conﬁrm the absence of any non-speciﬁc ampliﬁcation. The
eﬃciency of PCR for each primer pair was assessed using a serial di-
lution of 100 ng–0.01 ng of cDNA. Each qPCR experiment consisted of
at least 8 independent biological replicates with three technical re-
plicates for each. Data were analysed according to the 2−ΔΔCt method
(Pfaﬄ, 2001) in MS excel 365 (Microsoft). The expression level was
normalized to two validated reference genes, PLA2 (phospholipase A2)
and EEF1A (Supplementary Table 1) (Hornakova et al., 2010). Data was
visualised using GraphPad prism v7 (GraphPad Software, USA).
2.5. Baculovirus-mediated protein expression
B. terrestris CYP9Q6 and house ﬂy NADPH-dependent cytochrome
P450 reductase (CPR) (GenBank accession no. Q07994) were codon
optimised for expression in lepidopteran cell lines, synthesised by
GeneArt® (Life Technologies, USA), and inserted into the pDonor221
expression vector (Invitrogen). The recombinant baculovirus DNA was
synthesised in vitro and transfected into Trichoplusia ni High ﬁve™ cells
using the BaculoDirect C-term expression kit (Life Technologies, USA),
according to the manufacturer's protocol. The titre of the recombinant
virus was determined following protocols detailed by the supplier. High
Five™ cells (Life Technologies, USA), grown to a density of 2×106 cells
ml−1, were co-infected with recombinant baculoviruses containing
CYP9Q6 and CPR with a range of MOI (multiplicity of infection) ratios
to identify the optimal conditions. Control cells were co-infected with
the baculovirus containing vector with no insert (ctrl-virus) and the
recombinant baculovirus expressing CPR using the same MOI ratios.
Ferric citrate and δ-aminolevulinic acid hydrochloride were added to a
ﬁnal concentration of 0.1 mM at the time of infection and 24 h after
infection, to compensate for the low levels of endogenous heme in the
insect cells. Cells were harvested, washed with PBS, and microsomes
prepared according to standard procedures (Schenkman and Jansson,
2006) 48 h post infection. Brieﬂy, cells were homogenised for 30s in
0.1 M Na/K-phosphate buﬀer (pH 7.4), containing 1mM EDTA and
DTT, and 200mM sucrose, using a tissue grinder, and the homogenate
centrifuged for 10min at 680 g at 4 °C. The supernatant recovered was
centrifuged for 20min at 10,000 g and the decanted supernatant cen-
trifuged for a further 1 h at 100,000 g at 4 °C. The pellet obtained was
resuspended in 0.1 M Na/K-phosphate buﬀer (pH 7.6) containing 1mM
EDTA and DTT, and 10% v/v glycerol, using a Dounce tissue grinder.
Cytochrome P450 expression and functionality was estimated by mea-
suring the CO-diﬀerence spectra in reduced samples on a SLM AMINCO
Dual Wavelength Spectrophotometer DW 2000 (SLM instruments) and
scanning from 500 nm to 400 nm (Schenkman and Jansson, 2006). The
protein content of samples was determined using Bradford reagent
(Sigma-Aldrich, USA) and bovine serum albumin (BSA) as a reference.
2.6. Insecticide metabolism and model substrate proﬁling
Metabolism of thiacloprid and acetamiprid were assessed by in-
cubating recombinant P450/CPR (50μg/well) or control virus/CPR
(50μg/well) with a range of substrate concentrations (200-3.1 μM) in
the presence of an NADPH regeneration system (Promega, USA) at
30 ± 1 °C, shaking, for 1 h. Three replicates were performed for each
data point and the total assay volume was 200 μl. The breakdown rate
was assayed exactly as described above with a single concentration of
substrate (200 μM). Samples incubated without NADPH served as an
additional control. The reactions were terminated by the addition of
800 μl of ice-cold acetonitrile, centrifuged for 10min at 3000 g and the
supernatant subsequently analysed by tandem mass spectrometry as
described previously (Zhu et al., 2010). For chromatography on a
Waters Acquity HSS T3 column (2.1×50mm, 1.8 μm), acetonitrile/
water/0.1% formic acid was used as the eluent in gradient mode. For
detection and quantiﬁcation in positive ion mode, the MRM transitions
253 > 186, 269 > 202 (thiacloprid, OH-thiacloprid), and
223 > 126, 209 > 126 (acetamiprid and N-desmethyl acetamiprid)
were monitored. The peak integrals were calibrated externally against a
standard calibration curve. The linear range for the quantiﬁcation of
neonicotinoids and their hydroxylated (thiacloprid) and N-desmethy-
lated (acetamiprid) metabolites was 0.1–1000 ngml−1. Recovery rates
of parent compounds using microsomal fractions without NADPH were
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normally close to 100%. All statistical calculations and substrate turn-
over from two independent reactions were plotted vs. Controls and
Michaelis-Menten kinetics determined using GraphPad Prism version 7
(GraphPad Software, USA).
2.7. Generation of transgenic D. melanogaster
All Drosophila strains were maintained on standard ﬂy food
(Bloomington formulation) at 25 °C, on a 12/12 h light/dark cycle and
65% relative humidity. Cyp9Q6 was ampliﬁed from B. terrestris genomic
DNA and cloned into the attB-carrying plasmid pUAST
(pUASTattB_EF362409) using the EcoRI and XbaI restriction sites.
Injection mixes containing 0.5x phosphate buﬀer pH 6.8 (0.05 mM so-
dium phosphate, 2.5 mM KCl), 300 ng/μl of the pUAST-Cyp9Q6 con-
struct and 200 mg l−1 ﬂuorescein sodium salt were delivered into pre-
blastoderm embryos of an integration strain (y w M(eGFP, vas-int,
dmRFP)ZH-2A; P{CaryP}. attp40) sourced from the Fly Facility,
University of Cambridge, using an inverted microscope (eclipse TieU
Fig. 1. (A) Alignment of the two partial transcripts data-mined from the NCBI publicly available Bombus terrestris genome database with CYP9Q5. The overlapping
region of the two partial transcripts is highlighted. (B) Amino acid identity between CYP9Qs from B. terrestris (Bt) and A. mellifera (Am).
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Nikon, Japan) equipped with a 10x/0.25 lens, 10x/22 eyepiece and
ﬂuorescence illumination and a FemtoJet express micro-injector
(Eppendorf, Hamburg, Germany) controlled by a motorised
TransferMan NK2 micromanipulator (Eppendorf, Hamburg, Germany).
Injection needles were prepared according to Miller et al. (2002).
Survivors were back-crossed and F1 individuals were screened for the
presence of the white gene, which generates ﬂies with orange eyes.
Homozygous stocks for the integration of pUAST-Cyp9Q6 at attP40 were
generated by inter-crossing orange eyed ﬂies and selecting for red eyed
individuals. Control ﬂies carrying an empty pUAST plasmid were gen-
erated following the same procedures described above.
2.8. Transgenic D. melanogaster bioassays
The UAS/GAL4 system was used to drive the expression of Cyp9Q6.
Male ﬂies, homozygous for pUAST-Cyp9Q6 (UAS::CYP9Q6) or an empty
pUAST plasmid inserted at the same genomic location (UAS:empty),
were crossed to virgin females of a heat-shock inducible GAL4 driver
strain (w[*];P{wmC] = GAL4-Hsp70.PB}89-2-1) to generate
UAS::CYP9Q6/ + ;Hsp::GAL4/ + and UAS::empty/ + ;Hsp::GAL4/
+ strains, respectively. Overexpression of Cyp9Q6 in UAS::CYP9Q6/
+ ;Hsp::GAL4/ + ﬂies was conﬁrmed via qPCR with the UAS::CYP9Q6
parental strain used as a control for the relative comparisons. Reactions
were setup as presented in section 2.4, a single biological replicate
consisted of 5 heat-shock treated adult females. Over 600 four to eight-
day old female ﬂies from each genotype (UAS::CYP9Q6/
+ ;Hsp::GAL4/ + and UAS::empty/ + ;Hsp::GAL4/ + ) were selected
and used in contact/feeding bioassays. 24 h prior to bioassays, ﬂies
were heat-shock treated three times for 30 min at 37 °C, with 1-h in-
tervals, to induce the expression of Cyp9Q6. Groups of 20 ﬂies were
transferred to vials, previously coated with 100 μl of an insecticide di-
lution, containing 3ml of a settled agar-sucrose solution. Each bioassay
used ﬁve diﬀerent insecticide concentrations, ﬁve replications per
concentration and the number of dead ﬂies was recorded after 48 h.
Control mortality was assessed using vials containing agar-sucrose
without insecticide. Lethal concentrations (LC50 values) and 95% con-
ﬁdence limits were calculated by probit analysis using Genstat version
16 (VSN International, UK). Statistical signiﬁcance was calculated using
two tailed t-test in GraphPadprism version 7 (GraphPad Software, USA).
3. Results and discussion
Phylogeny (Supplementary ﬁgure 1) of the CYP9 P450 gene family
in the annotated genomes of Apis and Bombus revealed that A. mellifera
had three complete CYP9Q genes while B. terrestris had only two (the
previously characterised CYP9Q4 and CYP9Q5). To investigate if an
additional CYP9Q gene was present in B. terrestris we performed an in
silico re-analysis of P450 sequences in the B. terrestris genome.
3.1. Identiﬁcation of CYP9Q6 in the genome of B. terrestris
Two partial protein sequences (NCBI accession's XP_020718536.1
Fig. 2. (A and C) Kinetics of acetamiprid and thiacloprid for the CYP9Q sub-family. Data for CYP9Q4 and Q5 was collated from Manjon et al. (Manjon et al., 2018).
N=3, Km values shown on graph± standard deviation. Vmax values for Q6 are 62.44 ± 1.21 (acetamiprid), 60.87 ± 4.72 (thiacloprid). (B and D) Breakdown of
acetamiprid and thiacloprid by B. terrestris CYP9Q enzymes. CYP9Q4 and Q5 data taken from Manjon et al. (Manjon et al., 2018). Error bars represent standard
deviation, N = 3. Signiﬁcance is displayed above, NS- not signiﬁcant, **** P < 0.0001 (One-way ANOVA with Tukey test).
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and XP_003403396.2) with high level homology to the CYP9Q sub-fa-
mily were identiﬁed in the public protein database (Sadd et al., 2015)
by BLASTp searches using B. terrestris CYP9Q4 and CYP9Q5 sequences
as templates. Alignment of these partial transcripts to either CYP9Q4 or
CYPQ5 indicated they may correspond to diﬀerent regions of a novel,
full-length P450 sequence (Fig. 1A). tBLASTn of the partial protein
sequences against the B. terrestris genome identiﬁed two separate
genomic locations, NCBI accession's NC_015762.1 and
NW_003568850.1. Accession NC_015762.1 is a large scaﬀold previously
identiﬁed as the location of CYP9Q4 and CYP9Q5. The BLAST match
was located approximately 3000bp downstream of the CYP9Q4 gene
locus, immediately upstream of a sequence gap in the assembly.
Ampliﬁcation of the predicted novel ORF by RT-PCR yielded a
single 1.5 Kb cDNA, conﬁrming that the two partial transcripts are in
fact part of a single expressed mRNA. PCR on genomic DNA yielded the
same result, suggesting that the novel gene is intronless (as is the case
for CYP9Q4 and CYP9Q5, and CYP9Q1-3 of A. mellifera) and forms part
of the same genomic locus. Sequencing of both the genomic and re-
versed transcribed mRNA (cDNA) amplicons further conﬁrmed that this
is a novel, full-length P450 ORF. No premature stop codons were found
in either sequence suggesting that the gene is not a pseudogene and is
likely to be functional. The protein sequence of the novel gene shares
62.6% and 61.5% identity with CYP9Q4 and CYP9Q5 respectively and
55.4% identity with A. mellifera CYP9Q3 (Fig. 1B), known to be a pri-
mary metaboliser of N-cyanoamidine neonicotinoids in this species
(Manjon et al., 2018).
Previous work on the CYP9Q P450s in A. mellifera and B. terrestris
revealed high levels of expression of certain members of the family in
tissues with a known role in xenobiotic detoxiﬁcation or sites of in-
secticide action, such as the Malpighian tubules and the brain. Tissue
expression proﬁling of CYP9Q6 mRNA transcripts revealed a slightly
higher expression proﬁle in the bumblebee brain in comparison to the
midgut or Malpighian tubules (Fig. 3), although the brain expression
bias is much less pronounced in comparison to CYP9Q4 (Manjon et al.,
2018). These results are consistent with the high expression of A. mel-
lifera CYP9Q3 in the brain (Manjon et al., 2018), suggesting that B.
terrestris CYP9Q6 may play a similar functional role in protecting this
sensitive tissue from xenobiotics that cross the blood-brain barrier.
3.2. CYP9Q6 metabolises N-cyanoamidine neonicotinoids in vitro
To examine the capacity of CYP9Q6 to metabolise the N-cyanoa-
midine neonicotinoids thiacloprid and acetamiprid in vitro, CYP9Q6
was co-expressed with house ﬂy cytochrome P450 reductase (CPR) in
an insect cell line and microsomal preparations were incubated with
each insecticide. Analysis of the resulting metabolites, by liquid chro-
matography tandem mass spectrometry (LC-MS/MS), revealed that re-
combinant CYP9Q6 readily metabolises both compounds in the pre-
sence of NADPH (Fig. 2). The Km values for thiacloprid and acetamiprid
were 15.83 and 27.32 μM respectively, with Vmax values of 1.352 and
1.318 nmol product/nmol of active P450. Since the experimental setup
for CYP9Q6 directly mirrored the previously reported methods for
CYP9Q4 and CYPQ5, a direct comparison of the apparent rate of me-
tabolism for CYP9Q6 and the other two CYP9Q P450s was possible.
Data presented in Manjon et al. (2018) was converted from mg/ml to
active nmol P450 enzyme to normalise for any diﬀerence in the ex-
pression of active P450 (see Supplementary ﬁgure 3). This showed that
CYP9Q6 is 20 times more active at metabolising acetamiprid compared
to either CYP9Q4 or CYP9Q5, while it is 3 (CYP9Q4) and 16 (CYP9Q5)
times more active at metabolising thiacloprid. These results suggest that
CYP9Q6 is the more eﬃcient metaboliser for both compounds in B.
terrestris (Fig. 2).
3.3. Model-substrate proﬁle and catalytic site of CYP9Q6
A range of coumarin and resoruﬁn model substrates were tested
against CYP9Q6 expressed in microsomes. The enzyme does not exhibit
a particularly strong aﬃnity to any of these test compounds but did
demonstrate a slight preference for simple O-alkyl coumarins and re-
soruﬁns (Supplementary ﬁgure 2). This contrasts with the other two
previously described B. terrestris CYP9Q proteins, CYP9Q4 and
CYP9Q5, which only show activity against coumarins with methoxy
type moieties (Manjon et al., 2018). Thus, CYP9Q6 exhibits a greater
promiscuity when presented with model substrates although with a low
overall turnover. In contrast, A. mellifera CYP9Q3 eﬃciently metabo-
lises a broad range of coumarins (Manjon et al., 2018).
Protein alignments of CYP9Q6 with other members of the CYP9Q
sub-family revealed an amino acid substitution at a highly conserved
A(A,G)X(E,D)T motif of the I-Helix, known as the oxygen binding motif,
which is part of a substrate recognition site 4 (Fig. 4). In CYP9Q P450s
with high aﬃnity for N-cyanoamidine neonicotinoids, including bum-
blebee CYP9Q6 and honeybee CYP9Q3, a serine is found at the nor-
mally highly conserved threonine position within the motif. Likewise,
CYP9Q4, which metabolises both thiacloprid and acetamiprid, also
diverges from the conserved threonine and has an alanine substitution.
In contrast, other members of the CYP9Q family in A. mellifera (CYP9Q1
and CYP9Q2) and B. terrestris (CYP9Q5) which metabolise neonicoti-
noids with much lower eﬃciency, if at all, have the conserved threo-
nine (Manjon et al., 2018). Further evidence indicative of the potential
importance of the amino acid at this position comes from work on a
neonicotinoid resistant strain of brown planthopper Nilaparvata lugens
(Pang et al., 2016; Zimmer et al., 2018). In this example the CYP6ER1
P450 variant responsible for resistance to imidacloprid has a threonine
to serine substitution; replication of this serine substitution in the wild-
type enzyme resulted in a marked increase in the eﬃciency of imida-
cloprid detoxiﬁcation (Zimmer et al., 2018). Finally, a threonine to
proline substitution is found in an imidacloprid resistant strain of Be-
misia tabaci, where overexpression of CYP6CM1 is linked with imida-
cloprid resistance (Karunker et al., 2008). Molecular docking and dy-
namic simulations of the interactions of imidacloprid with this enzyme
revealed that Proline −326 forms part of the hydrophobic interface of
the binding cavity and may stabilize binding of imidacloprid in the
active site (Karunker et al., 2009).
Although the modiﬁcation of the threonine residue within the
oxygen binding motif appears to be important in allowing P450 en-
zymes to break down neonicotinoid compounds, it does not appear to
be essential since other P450's associated with neonicotinoid metabo-
lism, namely Myzus persicae CYP6CY3 (Bass et al., 2013) and Drosophila
melanogaster CYP6G1 (Joussen et al., 2008), do not have equivalent
substitutions at this position.
Fig. 3. Tissue-speciﬁc expression of CYP9Q6 transcripts in adult female worker.
Signiﬁcant diﬀerences in expression relative to the brain are indicated with *.
*P = 0.0089, **P = 0.0113 (two tailed T-test). N = 8 individual organs, error
bars represent 95% conﬁdence limits.
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3.4. CYP9Q6 expression in transgenic D. melanogaster
To further conﬁrm the role of CYP9Q6 in metabolising N-cyanoa-
midine neonicotinoids in vivo, we generated a transgenic line of D.
melanogaster expressing CYP9Q6 and examined its sensitivity to thia-
cloprid and acetamiprid. Expression of the transgene was conﬁrmed via
qPCR (Supplementary ﬁgure 4). In bioassays, ﬂies expressing the
CYP9Q6 transgene were signiﬁcantly more resistant to both insecticides
when compared to control ﬂies of the same genetic background without
the transgene (Tables 1 and 2). Flies expressing CYP9Q6 were ap-
proximately four times more resistant to thiacloprid (Table 1) and
around 2.3 times more resistant to acetamiprid (Table 2). These results
corroborate the metabolism assays with recombinant CYP9Q6 per-
formed in vitro and demonstrate that this P450 can confer tolerance to
thiacloprid and acetamiprid in vivo.
4. Conclusions
In summary, these data identify a novel CYP9Q P450 in B. terrestris
that metabolises N-cyanoamidine neonicotinoids with high eﬃciency.
This information, in combination with data on the previously char-
acterised CYP9Q4 and CYP9Q5, can be used to identify and conse-
quently avoid harmful pesticide eﬀects on B. terrestris that may arise
from the inadvertent inhibition of these enzymes (Mao et al., 2017). In
addition, by adding to the number of known insect P450 enzymes that
metabolise neonicotinoids, we highlight amino acids in the active site
of P450s that may be important determinants of binding and metabo-
lism of these compounds. This represents a useful starting point to
further characterise the structure/function determinants of neonicoti-
noid metabolism using site-directed mutagenesis.
Data availability
CYP9Q6 ORF and protein sequences were deposited on NCBI, ac-
cession no. MK559424.
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